GlassScriptPhysician profile
Joel J Smith
NPI 1760411193
$125,572.46
in general payments reported to CMS, 2019-2025
15 companies · $33K in 2025
The $33K reported for 2025 was more than what 94% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,745 · 2020: $11K · 2021: $6,519 · 2022: $5,787 · 2023: $27K · 2024: $41K · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $96K · Consulting Fee: $2,140 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,250 · Food and Beverage: $872.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $96,299.42 |
| Consulting Fee | $2,139.96 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,250.00 |
| Food and Beverage | $872.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $111,914.86 | 2021-2025 | Arthrex, Extremities & Trauma Implants Long Bone Trauma Tibial Fracture |
| Advanced Orthopaedic Solutions, INC. | $12,566.87 | 2019-2020 | |
| Johnson & Johnson Health Care Systems INC. | $524.00 | 2021 | |
| Stryker Corporation | $146.47 | 2019-2023 | Gamma |
| Depuy Synthes Sales INC. | $104.84 | 2019-2025 | Orthovisc |
| Smith+Nephew, INC. | $88.13 | 2023-2025 | Panta 2 |
| Paragon 28, INC. | $54.08 | 2023 | Monkey Rings, Portfolio |
| Moximed, INC | $29.92 | 2025 | Misha Knee System, Small, Left |
| Integra Lifesciences Corporation | $26.93 | 2020 | |
| Acumed LLC | $25.03 | 2022 | |
| Zimmer Biomet Holdings, INC. | $22.74 | 2019 | |
| Carbofix Orthopedics INC | $21.39 | 2022 | |
| Elevate Surgical Co | $16.74 | 2023 | |
| Linvatec Corporation | $15.64 | 2022 | |
| Innovation Technologies INC | $14.82 | 2024 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.